US recommends 'pause' to Johnson & Johnson jab rollout over blood clot fears
Related news coverage
Johnson & Johnson says it is delaying rollout of its COVID vaccine in Europe amid blood clot reports
Johnson & Johnson will delay the rollout of their COVID-19 vaccine in Europe following reports of blood clots in six people..
LONDON (AP) — Experts at the European Medicines Agency are preparing to present the conclusions of their investigation later on..